trans-2-en-valproate and dipropylacetamide

trans-2-en-valproate has been researched along with dipropylacetamide* in 1 studies

Reviews

1 review(s) available for trans-2-en-valproate and dipropylacetamide

ArticleYear
Can we develop improved derivatives of valproic acid?
    Pharmacy world & science : PWS, 1994, Feb-18, Volume: 16, Issue:1

    Valproic acid is one of the major antiepileptic drugs. In animal models, valproate showed less anticonvulsant potency than the other three established antiepileptic drugs: phenobarbital, phenytoin and carbamazepine. In addition, two major side-effects, teratogenicity and hepatotoxicity, have been associated with valproate therapy. Due to the above and the shortage of new antiepileptic drugs there is a substantial need to develop improved derivatives of valproate. This paper analyses three kinds of valproate derivatives: valpromide, the primary amide of valproate, and its analogues; monoester prodrugs of valproate and an active metabolite of valproate, 2-n-propyl-2-pentenoate. The comparative evaluation was carried out by pharmacokinetic and pharmacodynamic analyses in animals. From the data accumulated so far, we can conclude that 2-n-propyl-2-pentenoate and/or a valpromide isomer, which does not undergo amide-acid biotransformation and preferably is not an epoxide hydrolase inhibitor, may prove to be improved derivatives of the parent compound valproic acid.

    Topics: Animals; Anticonvulsants; Biotransformation; Drug Evaluation, Preclinical; Epilepsy; Fatty Acids, Monounsaturated; Prodrugs; Random Allocation; Stereoisomerism; Structure-Activity Relationship; Valproic Acid

1994